These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
677 related articles for article (PubMed ID: 31384529)
1. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Xia Q; Zhang Y; Li Z; Hou X; Feng N Acta Pharm Sin B; 2019 Jul; 9(4):675-689. PubMed ID: 31384529 [TBL] [Abstract][Full Text] [Related]
2. Carbon nanotubes for delivery of small molecule drugs. Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402 [TBL] [Abstract][Full Text] [Related]
3. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
4. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy. Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143 [TBL] [Abstract][Full Text] [Related]
6. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
7. Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy. Fu S; Li G; Zang W; Zhou X; Shi K; Zhai Y Acta Pharm Sin B; 2022 Jan; 12(1):92-106. PubMed ID: 35127374 [TBL] [Abstract][Full Text] [Related]
8. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200 [TBL] [Abstract][Full Text] [Related]
9. Enhanced photothermal therapy of biomimetic polypyrrole nanoparticles through improving blood flow perfusion. Wang X; Li H; Liu X; Tian Y; Guo H; Jiang T; Luo Z; Jin K; Kuai X; Liu Y; Pang Z; Yang W; Shen S Biomaterials; 2017 Oct; 143():130-141. PubMed ID: 28800434 [TBL] [Abstract][Full Text] [Related]
10. Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. Piao JG; Wang L; Gao F; You YZ; Xiong Y; Yang L ACS Nano; 2014 Oct; 8(10):10414-25. PubMed ID: 25286086 [TBL] [Abstract][Full Text] [Related]
11. Comparison of cell delivery and cell membrane camouflaged PLGA nanoparticles in the delivery of shikonin for colorectal cancer treatment. Zhou J; Jiang Z; Sun R; Pan D; Du Q; Zhou X; Chen Y; Chen Y; Peng J Colloids Surf B Biointerfaces; 2024 Sep; 241():114017. PubMed ID: 38865869 [TBL] [Abstract][Full Text] [Related]
12. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment. Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298 [TBL] [Abstract][Full Text] [Related]
13. Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers. Song M; Dong S; An X; Zhang W; Shen N; Li Y; Guo C; Liu C; Li X; Chen S J Control Release; 2022 May; 345():744-754. PubMed ID: 35381274 [TBL] [Abstract][Full Text] [Related]
14. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment. Li R; He Y; Zhang S; Qin J; Wang J Acta Pharm Sin B; 2018 Jan; 8(1):14-22. PubMed ID: 29872619 [TBL] [Abstract][Full Text] [Related]
15. Red Blood Cell Membrane Camouflaged Mesoporous Silica Nanorods as Nanocarriers for Synergistic Chemo-Photothermal Therapy. Zong S; Cao C; Chen K; Cui Y; Li J; Wang Z IEEE Trans Nanobioscience; 2023 Jul; 22(3):655-663. PubMed ID: 37015652 [TBL] [Abstract][Full Text] [Related]
16. Photosensitizer-loaded cell membrane biomimetic nanoparticles for enhanced tumor synergetic targeted therapy. Zhang Y; Ma N; Luo C; Zhu J; Bao C RSC Adv; 2020 Mar; 10(16):9378-9386. PubMed ID: 35497215 [TBL] [Abstract][Full Text] [Related]
17. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Yang M; Li J; Gu P; Fan X Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371 [TBL] [Abstract][Full Text] [Related]
18. Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer. Li M; Fang H; Liu Q; Gai Y; Yuan L; Wang S; Li H; Hou Y; Gao M; Lan X Biomater Sci; 2020 Mar; 8(7):1802-1814. PubMed ID: 32163070 [TBL] [Abstract][Full Text] [Related]
19. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy. Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in drug delivery systems for targeting cancer stem cells. Duan H; Liu Y; Gao Z; Huang W Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]